Drugs.com FDA MedWatch AlertsOriginal article
FDA Approves Additional Information in Labeling for Kybella (deoxycholic Acid) Injection Warning of Adverse Reactions Associated with Unapproved Use
RegulatoryapprovedKybellaNegative
AI Analysis
Summary
The FDA approved an additional warning in the labeling for Kybella (deoxycholic acid injection) to warn healthcare professionals and consumers about adverse reactions associated with unapproved uses of the drug.
Outcome Details
FDA approved additional warning in labeling regarding adverse reactions associated with unapproved use
Importance:3/10
Sentiment:
-0.30
FDAlabelingsafetywarningunapproved_use
Related Companies
Read the original article
Published by Drugs.com FDA MedWatch Alerts on September 15, 2026 9:07 AM